Clinical Trial Update: Investigation of Safety and Efficacy of Once-daily Semaglutide in Obese Subjects Without Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating once-daily semaglutide for safety and efficacy in obese adults without diabetes; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Metabolism and Nutrition Disorder, Obesity | Phase 2 | Status: COMPLETED | Results posted: 2020-04-17